OncoCyte Corp (NASDAQ:OCX)
| 4.85 Delayed Data As of Aug 05 |  +0.20 / +4.30%Today’s Change | 1.15 Today|||52-Week Range 6.57 | +102.93% Year-to-Date |
Latest OCX News | Press Releases
| Will OncoCyte (OCX) Report Negative Earnings Next Week? What You Should Know Aug 03 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 4.65 |
| Today’s open | 4.67 |
| Day’s range | 4.65 - 4.93 |
| Volume | 10,028 |
| Average volume (3 months) | 471,077 |
| Market cap | $462.8M |
Data as of 3:59pm ET, 08/05/2021
Growth & Valuation
| Earnings growth (last year) | -4.55% |
| Earnings growth (this year) | +31.55% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 128.69 |
| Price/Book | 10.45 |
Competitors
| ---- | ||
| SPROSpero Therapeutics I... | +0.51 | +3.73% |
| PLXPPLx Pharma Inc | +0.58 | +3.26% |
| MIRMMirum Pharmaceutical... | -0.09 | -0.62% |
Data as of 3:59pm ET, 08/05/2021
Financials
| Next reporting date | August 11, 2021 |
| EPS forecast (this quarter) | -$0.10 |
| Annual revenue (last year) | $1.2M |
| Annual profit (last year) | -$29.9M |
| Net profit margin | -2,461.51% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Irvine, California |
Forecasts
